Quest Diagnostics Incorporated (DGX) is a publicly traded diagnostics and research business based in the US. It opened the day at $135.15 after a previous close of $134.9. During the day the price has varied from a low of $133.06 to a high of $135.64. The latest price was $135.535 (25 minute delay). Quest Diagnostics Incorporated is listed on the NYSE and employs 40,000 staff. All prices are listed in US Dollars.
Best for
0% commission
Best for
Beginners
Best for
Beginner investments
BEST FOR
Transfer bonus
Both exchange rates and share prices fluctuate in real time, so the costs presented here should be considered as a guide only. They do not incorporate stamp duty. Always refer to the platform itself for availability and pricing – which may differ from our information.
| Platform | Customer rating | Platform fee | Min. initial deposit | Trading fee estimate | |
|---|---|---|---|---|---|
|
★★★★★ | £0 - £9.99 | No minimum | £3.19 £543.09 total |
Capital at risk |
|
★★★★★ | £0 | $50 | £2.70 £542.60 total |
Capital at risk |
|
★★★★★ | £0 | £250 | £10.71 £550.61 total |
Capital at risk |
 |
Not yet rated | £0 | No minimum | £2.70 £542.60 total |
Capital at risk |
 |
★★★★★ | £0 | £1 | £17.35 £557.25 total |
Capital at risk |
 |
★★★★★ | £0 | No minimum | £0.54 £540.44 total |
Capital at risk |
Full comparison of share dealing platforms
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Only you can make the decision on the time to leap. The gauge below shows real-time ratings that are based on 26 popular indicators such as moving averages, for specific time periods. It's not a recommendation but is simply technical analysis that can form part of your research.
Finder might not agree with the analysis and we take no responsibility. We also give no representations or warranty on the accuracy or completeness of the information provided on this page.
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value. Check out the Quest Diagnostics Incorporated P/E ratio, PEG ratio and EBITDA
Quest Diagnostics Incorporated's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 20x. In other words, Quest Diagnostics Incorporated shares trade at around 20x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Quest Diagnostics Incorporated's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.2373. A PEG ratio over 1 can be interpreted as meaning shares are overvalued at the current rate of growth, or may anticipate an acceleration in growth.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Quest Diagnostics Incorporated's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Quest Diagnostics Incorporated's EBITDA (earnings before interest, taxes, depreciation and amortisation) is a whopping $1.8 billion (£1.4 billion).
The EBITDA is a measure of a Quest Diagnostics Incorporated's overall financial performance and is widely used to measure a its profitability.
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Quest Diagnostics Incorporated.
Quest Diagnostics Incorporated's total ESG risk: 18.33
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Quest Diagnostics Incorporated's overall score of 18.33 (as at 01/01/2019) is excellent – landing it in it in the 16th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Quest Diagnostics Incorporated is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Quest Diagnostics Incorporated's environmental score: 0.86/100
Quest Diagnostics Incorporated's environmental score of 0.86 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Quest Diagnostics Incorporated is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Quest Diagnostics Incorporated's social score: 10.42/100
Quest Diagnostics Incorporated's social score of 10.42 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Quest Diagnostics Incorporated is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Quest Diagnostics Incorporated's governance score: 5.77/100
Quest Diagnostics Incorporated's governance score puts it squarely in the 1st percentile of companies rated in the same sector. That could suggest that Quest Diagnostics Incorporated is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Quest Diagnostics Incorporated's controversy score: 3/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. A high-profile company, Quest Diagnostics Incorporated scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that Quest Diagnostics Incorporated hasn't always managed to keep its nose clean.
Join 50,000 subscribers who are notified about expert money tips. Plus a chance to win £500!
By signing up you agree to receive emails from Finder and to the privacy policy and terms & conditions.
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
We take a closer look at the B2B buy now pay later services on offer with Mondu.
We explore how the Sainsbury’s Bank Everyday credit card lets you earn Nectar points as you spend.
This guide provides step-by-step instructions on how to buy Arbitrum, lists some exchanges where you can get it and provides daily price data on (ARB).
Now in their third year, these awards recognise the credit, loans, mortgage and BNPL providers displaying the best innovations in their field.
The winners of the Finder Lending Innovation Awards 2023 have been announced, find out who won across seven categories here.
Find out the winners and highly commended brands in the Finder Lending Innovation Awards 2023. The best lending innovation in the UK!
This guide provides step-by-step instructions on how to buy Sui, lists some exchanges where you can get it and provides daily price data on (SUI).
This guide provides step-by-step instructions on how to buy SSV Network, lists some exchanges where you can get it and provides daily price data on (SSV).
This guide provides step-by-step instructions on how to buy USDD, lists some exchanges where you can get it and provides daily price data on (USDD).
